In different murine models of T1D, anti-CD20 mAb suppresses the progression of β cell autoimmunity as well as reverses diabetes onset, by promoting Foxp3+Treg and regulatory B cell populations (121, 122). Here, FOXP3 is linked to type 1 diabetes mellitus.